Our Services
Medical Information
Helpful Resources
Published on: 10/5/2026
Glycopyrrolate is an oral anticholinergic that reduces heavy sweating by blocking acetylcholine at the sweat glands, and it is often prescribed off-label when antiperspirants alone fail to control hyperhidrosis of the face, scalp, hands, feet, or underarms. Relief usually begins within hours and can be dosed as needed, but the effect is temporary, varies widely between people, and does not cure the underlying cause. Common limits include dry mouth, blurred vision, constipation, urinary retention, and heat intolerance, plus cautions for glaucoma, certain heart conditions, and older adults, so dosing and candidacy differ by individual. There are several important factors to weigh before starting or switching treatment, including how to tell primary hyperhidrosis from sweating driven by thyroid problems, medications, infection, or menopause, which you can read about below.
If excessive sweating is disrupting your work, sleep, or confidence, a free, instant, online symptom check can help you organize your symptoms, flag possible causes worth ruling out, and prepare specific questions for a clinician so you reach the right next step faster.
Last reviewed for medical accuracy: 10/04/2026
Excessive sweating (hyperhidrosis) can interfere with daily activities, social interactions, and overall well-being. When over-the-counter antiperspirants and lifestyle changes aren’t enough, prescription medications like glycopyrrolate can help. Below, you’ll find an evidence-based look at glycopyrrolate for sweating—how it works, who it helps, potential side effects and limits, and when to talk to a doctor.
Glycopyrrolate is an anticholinergic medication originally approved for:
In recent years, providers have prescribed it off-label to reduce excessive sweating in areas such as the underarms, hands, feet, face and scalp.
Cholinergic Blockade
Systemic vs. Topical Action
Your doctor will tailor the dose based on:
Glycopyrrolate is considered when:
Because glycopyrrolate affects all cholinergic pathways, you may experience:
Most side effects are mild to moderate and improve with dose adjustment. However, persistent or severe reactions warrant prompt medical attention.
While glycopyrrolate can be very effective, it’s not a perfect solution:
| Treatment | Pros | Cons |
|---|---|---|
| Glycopyrrolate | Systemic relief; oral & topical | Anticholinergic side effects |
| Botox injections | Localized; months-long effect | Painful; expensive; requires clinic visits |
| Iontophoresis | Drug-free; home device | Time-consuming; skin irritation |
| Prescription antiperspirants (e.g., aluminum chloride) | Over-the-counter; inexpensive | Skin burning; limited effect on palms/soles |
Before starting glycopyrrolate for sweating:
Initial Check-In (2–4 weeks)
Regular Reviews (every 3–6 months)
Excessive sweating can sometimes signal an underlying health issue (e.g., thyroid problems, infections, diabetes). If you experience any of the following, talk to a doctor right away:
If you’re unsure of the cause of your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance.
Speak to your doctor before starting or adjusting glycopyrrolate, especially if you have other health conditions or take multiple medications. For any life‐threatening or serious concerns—such as sudden chest pain, severe heat intolerance or acute urinary retention—seek immediate medical attention.
(References)
* Goldstein DS, Pechnik S, Moak J, Eldadah B. Painful sweating. Neurology. 2004 Oct 26;63(8):1471-5. doi: 10.1212/01.wnl.0000142037.06255.a8. PMID: 15505167.
* Gordon JR, Hill SE. Update on pediatric hyperhidrosis. Dermatol Ther. 2013 Nov-Dec;26(6):452-61. doi: 10.1111/dth.12104. PMID: 24552408.
* Pariser DM, Ballard A. Topical therapies in hyperhidrosis care. Dermatol Clin. 2014 Oct;32(4):485-90. doi: 10.1016/j.det.2014.06.008. Epub 2014 Jul 29. PMID: 25152341.
* Glaser DA. Oral medications. Dermatol Clin. 2014 Oct;32(4):527-32. doi: 10.1016/j.det.2014.06.002. Epub 2014 Jul 29. PMID: 25152346.
* del Boz J. Systemic treatment of hyperhidrosis. Actas Dermosifiliogr. 2015 May;106(4):271-7. doi: 10.1016/j.ad.2014.11.012. Epub 2015 Jan 28. PMID: 25638324.
* Elston DM. Primum non nocere: Anticholinergics and dementia. J Am Acad Dermatol. 2018 Sep;79(3):439-440. doi: 10.1016/j.jaad.2018.03.016. PMID: 30119867.
* McConaghy JR, Fosselman D. Hyperhidrosis: Management Options. Am Fam Physician. 2018 Jun 1;97(11):729-734. PMID: 30215934.
* Chabicovsky M, Winkler S, Soeberdt M, Kilic A, Masur C, Abels C. Pharmacology, toxicology and clinical safety of glycopyrrolate. Toxicol Appl Pharmacol. 2019 May 1;370:154-169. doi: 10.1016/j.taap.2019.03.016. Epub 2019 Mar 21. PMID: 30905688.
* Nwannunu CE, Limmer AL, Coleman K, Shah R, Patel RR, Mui UN, Tyring SK. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis. Skin Therapy Lett. 2019 Mar;24(2):1-3. PMID: 30970203.
* Henning MAS, Bouazzi D, Jemec GBE. Treatment of Hyperhidrosis: An Update. Am J Clin Dermatol. 2022 Sep;23(5):635-646. doi: 10.1007/s40257-022-00707-x. Epub 2022 Jul 1. PMID: 35773437.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.